CFAO Healthcare has acquired Medimport, a leading pharmaceutical distributor in Mozambique, to strengthen its expansion in Lusophone Africa and enhance access to quality medicines.
Information on the Target
Medimport is one of the premier pharmaceutical distributors in Mozambique, recognized for its extensive distribution network and reliable supply of pharmaceutical products across the country. The company has established itself as a vital player in the healthcare sector, facilitating access to essential medicines and contributing to the overall improvement of health outcomes in the region.
By acquiring Medimport, CFAO Healthcare is poised to leverage its established reputation and distribution capabilities to enhance the quality and availability of healthcare products in Mozambique. This acquisition not only aligns with CFAO’s mission to provide high-quality healthcare solutions but also supports the country's growing demand for reliable pharmaceutical supply chains.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Mozambique
The pharmaceutical industry in Mozambique has been evolving steadily, driven by increased healthcare demands and a growing population. The government has taken significant steps to improve healthcare in
Similar Deals
Edwards Lifesciences → JenaValve Technology
2026
CFAO Healthcare
invested in
Medimport
in 2024
in a Other deal